Roundtable Discussion: What’s Next on the Horizon? Disease Model Indicators for a Targeted Intracellular Delivery Approach

Time: 12:00 pm
day: Day Two


  • What disease indications could most benefit from intracellular drug delivery investment?
  • Will specific payloads / technologies witness accelerated progress over the next 12 months?
  • Utilize this unique industry touchpoint to discuss and gain and understanding of where intracellular targeted delivery platform efforts should be diverted to support novel pipeline progression and research collaborations